Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

The Finnish Diabetes Prevention Study (DPS)

Lifestyle intervention and 3-year results on diet and physical activity

  1. Jaana Lindström, MSC1,
  2. Anne Louheranta, PHD2,
  3. Marjo Mannelin, MSC3,
  4. Merja Rastas, MSC4,
  5. Virpi Salminen, MSC5,
  6. Johan Eriksson, MD, PHD1,
  7. Matti Uusitupa, MD, PHD2,
  8. Jaakko Tuomilehto, MD, PHD16 and
  9. for the Finnish Diabetes Prevention Study Group
  1. 1Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
  2. 2Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
  3. 3Department of Sport Medicine, Oulu Deaconess Institute, Oulu, Finland
  4. 4Research and Development Centre, Social Insurance Institution, Turku, Finland
  5. 5Institute of Nursing and Health Care, Tampere, Finland
  6. 6Department of Public Health, University of Helsinki, Helsinki, Finland
  1. Address correspondence and reprint requests to Jaana Lindström, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. E-mail: jaana.lindstrom{at}ktl.fi
Diabetes Care 2003 Dec; 26(12): 3230-3236. https://doi.org/10.2337/diacare.26.12.3230
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Lifestyle intervention and 3-year results on diet and physical activity

Abstract

OBJECTIVE—To describe the 1) lifestyle intervention used in the Finnish Diabetes Prevention Study, 2) short- and long-term changes in diet and exercise behavior, and 3) effect of the intervention on glucose and lipid metabolism.

RESEARCH DESIGN AND METHODS—There were 522 middle-aged, overweight subjects with impaired glucose tolerance who were randomized to either a usual care control group or an intensive lifestyle intervention group. The control group received general dietary and exercise advice at baseline and had an annual physician’s examination. The subjects in the intervention group received additional individualized dietary counseling from a nutritionist. They were also offered circuit-type resistance training sessions and advised to increase overall physical activity. The intervention was the most intensive during the first year, followed by a maintenance period. The intervention goals were to reduce body weight, reduce dietary and saturated fat, and increase physical activity and dietary fiber.

RESULTS—The intervention group showed significantly greater improvement in each intervention goal. After 1 and 3 years, weight reductions were 4.5 and 3.5 kg in the intervention group and 1.0 and 0.9 kg in the control group, respectively. Measures of glycemia and lipemia improved more in the intervention group.

CONCLUSIONS—The intensive lifestyle intervention produced long-term beneficial changes in diet, physical activity, and clinical and biochemical parameters and reduced diabetes risk. This type of intervention is a feasible option to prevent type 2 diabetes and should be implemented in the primary health care system.

  • DPP, Diabetes Prevention Program
  • DPS, Diabetes Prevention Study
  • E%, proportion of total energy
  • OGTT, oral glucose tolerance test
  • LTPA, leisure-time physical activity
  • VLCD, very-low-calorie diet

The Finnish Diabetes Prevention Study (DPS) was one of the first controlled, randomized studies to show that type 2 diabetes is preventable with lifestyle intervention (1). The risk of diabetes was reduced by 58% in the intensive lifestyle intervention group compared with the control group. These results have been reproduced by the Diabetes Prevention Program (DPP), in which lifestyle intervention, with a similar 58% risk reduction, was superior to the metformin treatment (2). The lifestyle intervention used in the DPP was not designed to be used in community settings (3), whereas one of the main objectives in the DPS was to test an intervention feasible in primary health care.

In this study, we describe the lifestyle intervention program used in the DPS, the changes in dietary habits and exercise behavior that were achieved during the first year and the maintenance of these changes after 3 years, and assess the efficacy of the intervention on body weight, plasma glucose, and lipids.

RESEARCH DESIGN AND METHODS

The DPS was a multicenter study with five participating centers in Helsinki, Kuopio, Turku, Tampere, and Oulu. The study protocol was approved by the ethics committee of the National Public Health Institute in Helsinki, Finland. Each study center employed a physician, study nurse, and nutritionist (MSc in nutrition) on a part-time basis. Either an exercise instructor/physiotherapist was a member of the study team or these services were provided commercially.

Study subjects were recruited mainly by screening high-risk groups such as first-degree relatives of type 2 diabetes patients who voluntarily responded to local advertisements or were identified in earlier epidemiological surveys. The inclusion criteria were 1) age 40–64 years at screening, 2) BMI >25 kg/m2 at screening, and 3) the mean value of two 75-g oral glucose tolerance tests (OGTTs) in the impaired glucose tolerance range based on World Health Organization criteria (4). The randomization of participants (n = 522) started in 1993 and continued until 1998.

At the first study visit after the screening phase, the subjects were randomly allocated to the intervention group or the usual care control group. Randomization was stratified by center, sex, and 2-h plasma glucose value (1,5).

The study was prematurely terminated in March 2000 by an independent end point committee, since the incidence of diabetes in the intervention group was highly significantly lower than in the control group (1). However, the follow-up according to the original protocol was continued until each subject’s following annual visit. Therefore, the number of subjects who reached the 3-year visit in this report is somewhat higher (n = 434) than the number (n = 374) reported earlier (1).

Background for lifestyle intervention

The main goals of the lifestyle intervention were based upon available evidence on diabetes risk factors (6–9). They were weight reduction ≥5%, moderate intensity physical activity ≥30 min/day, dietary fat <30 proportion of total energy (E%), saturated fat <10 E%, and fiber ≥15 g/1,000 kcal.

The hypothesis of diabetes prevention by increased physical activity had already been tested in the Malmö feasibility study (10) with encouraging results. A nonrandomized pilot study testing the effect of aerobic and resistance training exercise programs on insulin resistance in subjects with impaired glucose tolerance was completed before the beginning of the DPS (11). On the basis of this pilot study, resistance training was offered to the participants of the DPS intervention.

To further increase the knowledge of a suitable diet for long-term intervention, a dietary pilot study was completed in a subgroup of subjects before the start of the DPS study (12). The results suggested that a monounsaturated fat–enriched diet improves glucose metabolism when consumed after a diet rich in saturated fat compared with a reduced-fat, polyunsaturated fat–enriched diet. Therefore, besides a moderate-fat (<30 E%), low–saturated fat (<10 E%) diet, a diet with somewhat more monounsaturated fat (total fat not exceeding 35 E%) was also considered acceptable.

At the nutritional counseling sessions, the intervention goals were translated into practice. General examples of this translation are presented in an online appendix (available at http://care.diabetesjournals.org).

Intervention group

Dietary intervention.

The participants had face-to-face consultation sessions (from 30 min to 1 h) with the study nutritionist at weeks 0, 1–2, and 5–6 and at months 3, 4, 6, and 9, i.e., altogether seven sessions during the first year and every 3 months thereafter. The first year sessions had a preplanned topic (e.g., diabetes risk factors, saturated fat, fiber, physical activity, and problem solving), but the discussions were individualized, focusing on specific individual problems. Printed material was used to illustrate the message and to serve as a reminder at home. In addition, there were voluntary group sessions, expert lectures, low-fat cooking lessons, visits to local supermarkets, and between-visit phone calls and letters. The goal was to equip the subjects with necessary knowledge and skills and to achieve gradual, permanent behavioral changes. A change in behavior was considered a process, as suggested by Prochaska (13). The dietary advice was based on 3-day food records, which were completed four times yearly. Nutrient intakes were calculated, and a summary of the results was given and explained to the subjects. Subjects were encouraged to make intermediate goals for themselves by thinking about practical things they could try to change (e.g., instead of an abstract goal such as “increase fiber intake,” a practical goal would be “eat a slice of rye bread on every meal”). Weight was measured at every visit, and a weight chart was drawn. The participants were also encouraged to measure and record their weight at home on a regular basis. Recommended weight loss was not more than 0.5 to 1 kg per week. The spouse was invited to join the sessions, especially if he or she was the one responsible for shopping and cooking in the family. After 6 months, the use of a very-low-calorie diet (VLCD) for 2–5 weeks or as a substitute for one to two meals per day was considered, if preferred by the subject, to boost weight loss. Altogether, 48 subjects participated in the VLCD groups arranged as part of the intensive intervention.

Exercise intervention.

The subjects were individually guided to increase their overall level of physical activity. This was done by the nutritionist during the dietary counseling sessions and highlighted by the study physicians at the annual visits. Endurance exercise was recommended to increase aerobic capacity and cardiorespiratory fitness. Supervised, progressive, individually tailored circuit-type moderate intensity resistance training sessions to improve the functional capacity and strength of the large muscle groups of the upper and lower body were also offered free of charge. As a means for improving motivation, an “exercise competition” between the five study centers was organized twice during the study period. Voluntary group walking and hiking were also organized.

Education program for the control group

At baseline, the control group was given general information about lifestyle and diabetes risk. This was done either individually or in one group session (30 min to 1 h), and some printed material was delivered. The message to reduce weight, increase physical activity, and make qualitative changes in diet was the same as for the intervention group subjects, but counseling was not individualized.

Baseline and annual measurements

All study subjects had an annual OGTT, a medical history, and a physical examination with measurements of height, weight, and waist circumference. These procedures have been described in detail previously (1,5). Plasma, serum, or capillary glucose was determined locally according to standard guidelines and corrected by linear regression equation using values measured in the National Public Health Institute central laboratory (60–80 duplicate plasma samples per center) as the dependent variable. The second screening OGTT was considered the glucose baseline. Diabetes diagnosis had to be confirmed by a second OGTT and induced termination of the study. Serum total cholesterol, HDL cholesterol, and triglycerides were determined using an enzymatic assay method. HbA1c was analyzed using the Bayer DCA2000 Analyzer.

Those study subjects who terminated the follow-up prematurely were defined as dropouts. Nevertheless, data from their earlier visits were included in the analyses. There were 8 and 6 subjects who did not attend the 1-year annual visit and an additional 9 and 9 who did not attend the 3-year visit in the intervention and control groups, respectively.

Assessment of dietary intake

Study subjects were asked to complete a 3-day food record at baseline (before the randomization visit) and before every annual visit. A picture booklet of portion sizes of typical foods was used to estimate the amount of food consumed (14). The nutrient intakes were calculated using a dietary analysis program developed in the National Public Health Institute (15). The program allows modification of database recipes, so that the subjects could account for changes made to traditional recipes (e.g., the use of skim instead of whole milk). For this report, the most recent nutrient content dataset was used, and therefore the nutrient intake results are slightly different from those reported previously (1).

Assessment of physical activity

The study subjects completed the validated Kuopio Ischaemic Heart Disease Risk Factor Study 12-month Leisure-Time Physical Activity (LTPA) questionnaire (16,17) at baseline and at every annual visit. In this detailed quantitative questionnaire, subjects estimated the frequency (times per month), duration (minutes), and intensity (0, recreational and outdoor activities; 1, conditioning exercise; 2, brisk conditioning exercise; and 3, competitive strenuous exercise) of their most common lifestyle and structured LTPA over the previous 12 months. Common moderate- or high-intensity physical activity included brisk walking, skiing, jogging, swimming, bicycling, gymnastics, resistance training, and ball games (if reported intensity ≥1); gardening and snow shoveling, hunting, picking berries, and gathering mushrooms (if reported intensity ≥2); fishing, hobby crafts, and repairs and house work (if reported intensity = 3); and rowing, forest work, and wood cutting (if reported intensity ≥1). The duration (minutes per week) of total physical activity and moderate- and high-intensity LTPA were calculated.

Statistical analysis

Differences between the intensive intervention and control group were tested for statistical significance with Student’s t test (approximately normally distributed variables), Mann-Whitney nonparametric test, χ2 test, or ANCOVA adjusting for baseline value, using SAS software (SAS Institute, Cary, NC) version 8.2.

RESULTS

Baseline results

At baseline, the study groups were similar in terms of characteristics reflecting increased diabetes risk (Table 1). Of all study subjects, 55% had a BMI >30 kg/m2. The median amount of at least moderate-intensity LTPA was 160 min/week. In their spare time, 34% of the study subjects reported that they mostly read, watched TV, and spent time in other ways that are not physically demanding; these individuals were considered sedentary (not shown). Dietary intake of both macro- and micronutrients were similar between the groups except for the energy proportion of saturated fat, which was slightly higher in the control group.

1- and 3-year results

Physical activity.

The proportion of sedentary individuals was 14 and 30% at year 1 (P < 0.0001 for difference between groups) and 17 and 29% at year 3 (P = 0.0028) in the intervention and control groups, respectively. However, the total amount of reported time spent physically active did not change, but moderate-to-vigorous LTPA increased in the intervention group compared with the control group at years 1 and 3 (Table 2).

Dietary intake.

The E% of carbohydrates increased; the E% of fat, saturated fat, and also monounsaturated fat decreased; the fiber density increased; and cholesterol intake decreased more in the intervention group compared with the control group during the first year (Table 2). The absolute amounts of fat decreased, and energy intake decreased in the intervention group more than in the control group. At 3 years the reductions in energy, fat (E% and g), saturated fat (E%), and monounsaturated fat (E%), and the increase in carbohydrates (E%) and fiber density were still statistically significantly greater in the intervention group.

The specific goals of the intervention were more often reached by the intervention group than the control group subjects. Of the intervention and control group subjects, 46 and 14% managed to lose ≥5% of weight during the first year (P < 0.0001), the fat intake goal was reached by 37 and 20% (P < 0.0001), the saturated fat intake goal was reached by 21 and 9% (P < 0.0001), and the fiber density goal was reached by 37 and 23% (P < 0.0006), respectively. In general, women tended to change their diet more than men, but there was no interaction between group assignment and sex (not shown).

Clinical and metabolic parameters.

Several beneficial changes in clinical and metabolic parameters were observed in the intervention group compared with the control group at year 1 and still at the year 3 examination (Table 3). Mean weight reduction was 4.5 kg in the intervention group and 1.0 kg in the control group at 1 year. Some regain of weight appeared during the following 2 years. After exclusion of those intervention group subjects who took part in the VLCD group (whose weight reduction was 6.2 ± 7.0 kg at year 1 and 4.8 ± 7.2 kg at year 3), the mean weight reduction was 4.1 ± 4.3 kg at year 1 and 3.2 ± 4.5 kg at year 3 (P < 0.0001 compared with the control group).

Significantly greater improvements were seen at year 1 in fasting plasma glucose (−0.2 vs. 0.0 mmol/l), 2-h plasma glucose (−0.9 vs. −0.3 mmol/l), HbA1c (−0.1 vs. 0.1%), serum total cholesterol–to–HDL cholesterol ratio (−0.4 vs. −0.1), and serum triglycerides (−0.2 vs. −0.0 mmol/l) in the intervention group compared with the control group. During the first 3 years of the study, 22 subjects (9%) in the intervention group and 51 (20%) in the control group developed diabetes (P = 0.0001, χ2 test). The use of VLCD preparations did not affect diabetes risk; 8% of the users developed diabetes in 3 years.

CONCLUSIONS

It is evident that lifestyle intervention can prevent or at least postpone type 2 diabetes (1,2,18) and should therefore be implemented in primary health care. However, the lifestyle interventions used have been either insufficiently described (18) or not intended as conventional treatment of high-risk individuals (3). In this study we describe the intervention used in the DPS in detail in order to enable utilization of our experience by others.

The intensive lifestyle intervention induced several beneficial changes in diet, physical activity, blood glucose, and lipid concentrations and a highly significant reduction in diabetes incidence. The intervention program was most intensive during the first year, and consequently the changes in clinical characteristics were most prominent after the first year. The effect of intervention, e.g., the differences between the intensive intervention and the control groups, was somewhat attenuated at 3 years, but this result may be biased due to the study design. Those subjects who developed diabetes during the first 2 years of the trial did not have a 3-year examination; the majority belonged to the control group. Furthermore, the control group subjects were actually given a “mini-intervention” and therefore were not a true nontreatment group.

The weight reduction during the study was modest but comparable with that of other studies (10,19–21) on subjects with the metabolic syndrome, impaired glucose tolerance, or type 2 diabetes and using lifestyle approach to weight reduction. In the DPP study, a highly intensive and therefore expensive lifestyle intervention (3,22) produced a 5.6-kg weight reduction during the first year of intervention, with slight, gradual regain at the end of the study, i.e., 4 years (2).

Maintenance of the weight reduction after the 1-year intensive intervention period was satisfactory. It has been speculated that greater initial weight loss achieved with the use of VLCD preparations or with drugs might predict better long-term results (23). In our study, those not satisfied with the weight reduction achieved with the core program benefited from supplementary VLCD treatment, and their diabetes incidence was similar to those not using VLCD.

Independent of weight loss, calorie restriction results in improved glucose metabolism in subjects with type 2 diabetes (24,25). It can be speculated that small negative energy balance sustained for a lengthy time period could be more advantageous to glucose tolerance than similar weight loss achieved with strict, short-term energy restriction. Therefore, in the long run, a lifestyle-intervention approach to weight control rather than a weight-reduction diet might be a more cost-efficient way to manage overweight in individuals at high risk for diabetes.

We used one-to-one intervention to individualize the intervention and because the recruitment and screening of study subjects was gradual. Group care may have some benefits in the form of social support and would probably be more cost-efficient in the clinical setting, where there is no need for accurate collection of food intake data.

The habitual nutrient intakes of the study subjects were estimated using 3-day food records, which is a reliable method in analyzing dietary intakes of groups. A well-known phenomenon in dietary analyses is underreporting, which is even more prominent in overweight individuals (26). The relatively low energy intakes indicate that some underreporting has taken place in our study. On the other hand, our analyses are based on differences between the two groups, and underreporting is presumably similar in both groups. Moreover, under- and overreporting has been shown to be subject specific (27), and as we measure changes in dietary intake within a person, the bias may be attenuated.

The frequency, duration, and intensity of leisure time and lifestyle physical activity during the preceding 12 months were estimated by the study subjects at each annual visit. It was not straightforward and may have been incomplete due to difficulty recollecting, especially occasional activities. The majority of the study subjects considered themselves at least moderately active (≥4 h/week of some kind of physical activity), but based on the LTPA questionnaire most of their activity was low intensity. The reported time spent on moderate- and high-intensity LTPA increased slightly in the intervention group compared with the control group. If other types of supervised exercise in addition to the circuit-type resistance training sessions had been offered, then the increment might have been higher.

The main finding in the DPS was that nonpharmacologic lifestyle intervention of people at high risk for diabetes does prevent or at least postpone the onset of type 2 diabetes. The observed difference in incidence between the intensive intervention and the usual care control group indicates that the intervention needs to be individualized and continuing and performed by skilled professionals in order to be effective. The lifestyle intervention program used in the DPS is practical and can be implemented in primary health care systems.

View this table:
  • View inline
  • View popup
Table 1—

Baseline characteristics

View this table:
  • View inline
  • View popup
Table 2—

Changes in physical activity and nutrient intakes from baseline to years 1 and 3

View this table:
  • View inline
  • View popup
Table 3—

Changes in clinical and metabolic characteristics from baseline to years 1 and 3

Acknowledgments

The DPS study has been financially supported by the Finnish Academy, Ministry of Education, Novo Nordisk Foundation, Yrjö Jahnsson Foundation, Juho Vainio Foundation, and Finnish Diabetes Research Foundation.

We are indebted to the DPS research team members for their skillful contribution in performing the study, Dr. Timo Lakka and Prof. Jukka T. Salonen for advice concerning exercise assessment, and Markku Peltonen, PhD, for statistical advice.

Footnotes

  • Additional information for this article can be found in an online appendix at http://care.diabetesjournals.org.

    A table elsewhere in this issue shows conventional and Systéme International (SI) units and conversion factors for many substances.

    • Accepted September 4, 2003.
    • Received July 17, 2003.
  • DIABETES CARE

References

  1. ↵
    Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350, 2001
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    The Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    The Diabetes Prevention Program Research Group: The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165–2171, 2002
    OpenUrlAbstract/FREE Full Text
  4. ↵
    World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
  5. ↵
    Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J: Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland: study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793–801, 1999
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34:1055–1058, 1985
    OpenUrlAbstract/FREE Full Text
  7. Ohlson LO, Larsson B, Björntorp P, Eriksson H, Svardsudd K, Welin L, Tibblin G, Wilhelmsen L: Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31:798–805, 1988
    OpenUrlPubMedWeb of Science
  8. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE: Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132:501–513, 1990
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Cassano PA, Rosner B, Vokonas PS, Weiss ST: Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus: a prospective cohort study of men in the normative aging study. Am J Epidemiol 136:1474–1486, 1992
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Eriksson KF, Lindgärde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia 34:891–898, 1991
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Eriksson J, Tuominen J, Valle T, Sundberg S, Sovijärvi A, Lindholm H, Tuomilehto J, Koivisto V: Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance? Horm Metab Res 30:37–41, 1998
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Sarkkinen E, Schwab U, Niskanen L, Hannuksela M, Savolainen M, Kervinen K, Kesäniemi A, Uusitupa MI: The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 50:592–598, 1996
    OpenUrlPubMedWeb of Science
  13. ↵
    Prochaska JO, DiClemente CC, Norcross JC: In search of how people change: applications to addictive behaviors. Am Psychol 47:1102–1114, 1992
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Haapa E, Toponen T, Pietinen P, Räsänen L: Annoskuvakirja. Helsinki, Finland, Painokaari Oy, 1985
  15. ↵
    Ovaskainen M-L, Valsta L, Lauronen J: The compilation of food analysis values as a database for dietary studies: the Finnish experience. Food Chemistry 57:133–136, 1996
  16. ↵
    Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT: Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554, 1994
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Lakka TA, Salonen JT: Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 21:467–472, 1992
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544, 1997
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Swinburn BA, Metcalf PA, Ley SJ: Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 24:619–624, 2001
    OpenUrlAbstract/FREE Full Text
  20. Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, Robinson E, Wareham NJ: Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr 75:11–20, 2002
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE: Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord 27:377–384, 2003
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    The Diabetes Prevention Program Research Group: Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26:36–47, 2003
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Astrup A, Rössner S: Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev 1:17–19, 2000
    OpenUrlCrossRefPubMed
  24. ↵
    Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M: Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Endocrinol Metab 77:1287–1293, 1993
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN: Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17:30–36, 1994
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Livingstone MBE, Black AE: Markers of the validity of reported energy intake (Review). J Nutr 133(Suppl. 3):895S–920S, 2003
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Black AE, Cole TJ: Biased over- or under-reporting is characteristic of individuals whether over time or by different assessment methods. J Am Diet Assoc 101:70–80, 2001
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Diabetes Care: 26 (12)

In this Issue

December 2003, 26(12)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Finnish Diabetes Prevention Study (DPS)
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Finnish Diabetes Prevention Study (DPS)
Jaana Lindström, Anne Louheranta, Marjo Mannelin, Merja Rastas, Virpi Salminen, Johan Eriksson, Matti Uusitupa, Jaakko Tuomilehto
Diabetes Care Dec 2003, 26 (12) 3230-3236; DOI: 10.2337/diacare.26.12.3230

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Finnish Diabetes Prevention Study (DPS)
Jaana Lindström, Anne Louheranta, Marjo Mannelin, Merja Rastas, Virpi Salminen, Johan Eriksson, Matti Uusitupa, Jaakko Tuomilehto
Diabetes Care Dec 2003, 26 (12) 3230-3236; DOI: 10.2337/diacare.26.12.3230
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Risk Factors for Mortality Among Patients With Diabetes
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.